{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:06:38Z","timestamp":1765667198368},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Isoniazid is recommended for prevention of tuberculosis (TB) in HIV-infected adults, but its efficacy in children living with HIV (CLHIV) is not known. We performed a systematic review to assess the efficacy of isoniazid for the prevention of TB in CLHIV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched PubMed, Cochrane Clinical Trial Registry and Google Scholar from inception to December 2016. Any randomized controlled trial assessing the role of isoniazid for the prevention of TB in CLHIV was eligible for inclusion. The primary endpoint was TB incidence; secondary end points were mortality, overall survival and severe adverse events. Dual independent extraction of all data was performed. Data were pooled under a random effects model and summarized either as risk ratio (RR) or hazard ratio along with 95% confidence intervals (CIs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 931 references, 3 randomized controlled trials enrolling 977 patients met the inclusion criteria. Pooled results showed a statistically nonsignificant reduction in TB incidence (RR: 0.70; 95% CI: 0.47\u20131.04; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.07) and mortality (RR: 0.94; 95% CI: 0.39\u20132.23; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.88) with the use of isoniazid compared with placebo. One study was stopped early because of excess deaths in the placebo arm. However, results from subgroup analysis restricted to only completed trials did not change the overall findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Isoniazid did not reduce the incidence of TB in CLHIV. All included studies were performed in regions with high prevalence of TB making the overall generalizability limited.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001879","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T17:07:25Z","timestamp":1514394445000},"page":"773-780","source":"Crossref","is-referenced-by-count":12,"title":["Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children"],"prefix":"10.1097","volume":"37","author":[{"given":"Jaykaran","family":"Charan","sequence":"first","affiliation":[{"name":"Department of Pharmacology, All Indian Institute of Medical Sciences, Jodhpur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish Prasad","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All Indian Institute of Medical Science, Rishikesh, Uttrakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tea","family":"Reljic","sequence":"additional","affiliation":[{"name":"Internal Medicine, Evidence Based Medicine, USF Health Program for Comparative Effectiveness Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Emmanuel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Patel","sequence":"additional","affiliation":[{"name":"Infectious Disease, Vedanta Institute of Medical Sciences, Ahmedabad, Gujarat, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Internal Medicine, Evidence Based Medicine, USF Health Program for Comparative Effectiveness Research"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(14)70245-1","article-title":"Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study.","volume":"2","author":"Dodd","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4314\/ahs.v15i3.20","article-title":"Prevalence and risk factors of latent tuberculosis among adolescents in rural Eastern Uganda.","volume":"15","author":"Mumpe-Mwanja","year":"2015","journal-title":"Afr Health Sci"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s10903-015-0273-2","article-title":"Latent tuberculosis infection among immigrant and refugee children arriving in the United States: 2010.","volume":"18","author":"Taylor","year":"2016","journal-title":"J Immigr Minor Health"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/INF.0b013e318239e268","article-title":"Reduction in mycobacterial disease among HIV-infected children in the highly active antiretroviral therapy era (1997-2008).","volume":"31","author":"Jensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230912","first-page":"839","article-title":"Risk of development of tuberculosis in HIV-infected patients.","volume":"4","author":"Swaminathan","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00002030-199709000-00011","article-title":"Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, C\u00f4te d\u2019Ivoire.","volume":"11","author":"Mukadi","year":"1997","journal-title":"AIDS"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"issue":"suppl 5","key":"R10-20230912","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/01.aids.0000391010.02774.6f","article-title":"Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.","volume":"24","author":"Charalambous","year":"2010","journal-title":"AIDS"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5588\/ijtld.11.0402","article-title":"Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.","volume":"16","author":"Khawcharoenporn","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1011214","article-title":"Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children.","volume":"365","author":"Madhi","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39000.486400.55","article-title":"Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.","volume":"334","author":"Zar","year":"2007","journal-title":"BMJ"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5588\/ijtld.13.0354","article-title":"Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.","volume":"18","author":"Gray","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2334-14-91","article-title":"Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis.","volume":"14","author":"Ayieko","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R16-20230912","first-page":"1428","article-title":"Cochrane review: impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.","volume":"4","author":"Gray","year":"2009","journal-title":"EBCH"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot.","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"key":"R27-20230912","first-page":"Cd000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons.","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201808000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:14:06Z","timestamp":1694556846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201808000-00011"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001879","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}